540
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Correlation Between Benign Prostatic Hyperplasia/Lower Urinary Tract Symptoms and Renal Function in Elderly Men Aged 80 Years and Older

, , , , , , & show all
Pages 61-69 | Received 07 Oct 2022, Accepted 04 Jan 2023, Published online: 13 Jan 2023

References

  • Madersbacher S, Sampson N, Culig Z. Pathophysiology of benign prostatic hyperplasia and benign prostatic enlargement: a mini-review. Gerontology. 2019;65(5):458–464. doi:10.1159/000496289
  • O’Sullivan E, Hughes J, Ferenbach D. Renal aging: causes and consequences. J Am Soc Nephrol. 2017;28:407–420. doi:10.1681/ASN.2015121308
  • Tamalunas A, Westhofen T, Schott M, et al. Holmium laser enucleation of the prostate: a truly size-independent method? Low Urin Tract Symptoms. 2022;14:17–26. doi:10.1111/luts.12404
  • Rule AD, Lieber MM, Jacobsen SJ. Is benign prostatic hyperplasia a risk factor for chronic renal failure? J Urol. 2005;173:691–696. doi:10.1097/01.ju.0000153518.11501.d2
  • AUA Practice Guidelines Committee. AUA guideline on management of benign prostatic hyperplasia (2003). Chapter 1: diagnosis and treatment recommendations. J Urol. 2003;170(170):530–547. doi:10.1097/01.ju.0000078083.38675.79
  • Welliver C, Feinstein L, Ward J, et al. Poor clinical guideline adherence and inappropriate testing for incident lower urinary tract symptoms associated with benign prostatic hyperplasia. Prostate Cancer Prostatic Dis. 2022;25(2):269–273. doi:10.1038/s41391-021-00435-z
  • Zhang X, Wang X, Wang G, et al. Clinical guideline for the diagnosis and treatment of benign prostatic hyperplasia. Chin J Surg. 2007;45:1704–1707.
  • Lerner L, McVary K, Barry M, et al. Management of lower urinary tract symptoms attributed to benign prostatic hyperplasia: AUA GUIDELINE PART I-initial work-up and medical management. J Urol. 2021;206:806–817. doi:10.1097/JU.0000000000002183
  • Stevens P, Lamb E, Levin A. Integrating guidelines, CKD, multimorbidity, and older adults. Am J Kidney Dis. 2015;65:494–501. doi:10.1053/j.ajkd.2014.09.024
  • Hallan S, Kwong D, Vikse B, Stevens P. Use of a prostate symptom score to identify men at risk of future kidney failure: insights from the HUNT II Study. Am J Kidney Dis. 2010;56:477–485. doi:10.1053/j.ajkd.2010.03.021
  • Malhotra R, Katz R, Jotwani V, et al. Estimated GFR variability and risk of cardiovascular events and mortality in SPRINT (Systolic Blood Pressure Intervention Trial). Am J Kidney Dis. 2021;78:48–56. doi:10.1053/j.ajkd.2020.10.016
  • Gee W, Holtgrewe H, Albertsen P, et al. Practice trends in the diagnosis and management of benign prostatic hyperplasia in the United States. J Urol. 1995;154:205–206. doi:10.1016/S0022-5347(01)67269-0
  • Gratzke C, Bachmann A, Descazeaud A, et al. EAU guidelines on the assessment of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction. Eur Urol. 2015;67:1099–1109. doi:10.1016/j.eururo.2014.12.038
  • Rule A, Jacobson D, Roberts R, et al. The association between benign prostatic hyperplasia and chronic kidney disease in community-dwelling men. Kidney Int. 2005;67:2376–2382. doi:10.1111/j.1523-1755.2005.00344.x
  • Hong S, Lee S, Jeong S, et al. Chronic kidney disease among men with lower urinary tract symptoms due to benign prostatic hyperplasia. BJU Int. 2010;105:1424–1428. doi:10.1111/j.1464-410X.2009.08975.x
  • Lee J, Kwon H, Park Y, Cho I, Min S. Relationship of estimated glomerular filtration rate with lower urinary tract symptoms/benign prostatic hyperplasia measures in middle-aged men with moderate to severe lower urinary tract symptoms. Urology. 2013;82:1381–1385. doi:10.1016/j.urology.2013.07.049
  • Kwon Y, Cho B, Son K, Choi H, Park S, Park J. Lower urinary tract symptoms have negative associations with glomerular filtration rate irrespective of prostate volume in Korean men. Urology. 2012;79:182–187. doi:10.1016/j.urology.2011.08.011
  • Lai S, Pastore S, Piloni L, et al. Chronic kidney disease and urological disorders: systematic use of uroflowmetry in nephropathic patients. Clin Kidney J. 2019;12:414–419. doi:10.1093/ckj/sfy085
  • Sarier M, Tekin S, Duman İ, et al. Results of transurethral resection of the prostate in renal transplant recipients: a single center experience. World J Urol. 2018;36:99–103. doi:10.1007/s00345-017-2094-5
  • Sarier M, Duman I, Kilic S, et al. Comparative results of transurethral incision with transurethral resection of the prostate in renal transplant recipients with benign prostate hyperplasia. Urol J. 2018;15:209–213. doi:10.22037/uj.v0i0.4074
  • Hamm R, MacDermott S. Renal function in men with lower urinary tract symptoms at first presentation to urology out-patient department. Ann R Coll Surg Engl. 2004;86:182–185. doi:10.1308/003588404323043319
  • Ponholzer A, Temml C, Obermayr R, Rauchenwald M, Madersbacher S. The association between lower urinary tract symptoms and renal function in men: a cross-sectional and 5-year longitudinal analysis. J Urol. 2006;175:1398–1402. doi:10.1016/S0022-5347(05)00641-5
  • Abello A, DeWolf W, Das A. Expectant long-term follow-up of patients with chronic urinary retention. Neurourol Urodyn. 2019;38:305–309. doi:10.1002/nau.23853
  • Tamalunas A, Westhofen T, Schott M, et al. The impact of preoperative lower urinary tract symptoms medication on the functional performance of holmium laser enucleation of the prostate. Cent Eur J Urol. 2021;74:429–436. doi:10.5173/ceju.2021.130
  • Tamalunas A, Westhofen T, Schott M, et al. The clinical value of holmium laser enucleation of the prostate in octogenarians. Low Urin Tract Symptoms. 2021;13:279–285. doi:10.1111/luts.12366